The Food and Drug Administration announced March 8 that it is deactivating a 2016 import alert that prevented genetically engineered salmon from entering the U.S.
The FDA states that in 2015 it approved an application related to a genetically engineered Atlantic salmon that contains the first approved intentional genomic alteration in an animal intended for food use. However, in 2016 Congress directed the FDA not to allow any food that contains GE salmon into commerce until final labeling guidelines for informing consumers of the GE salmon content in the food were issued. The FDA complied by implementing an import alert in 2016.
However, Congress subsequently enacted the National Bioengineered Food Disclosure Standard, which charges the Department of Agriculture with implementing a mandatory standard for disclosing whether a food is bioengineered and divests the FDA of its authority over voluntary labeling to indicate the presence of GE content in human foods. The FDA believes this mandate has been satisfied by the USDA’s issuance of final regulations implementing that law in late 2018.
The FDA is therefore deactivating the 2016 import alert, meaning eggs from this GE salmon can now be imported to be raised into salmon for food.
For more information on FDA import alerts, including how to get a product removed from an import alert, please contact Shelly Garg at (305) 894-1043.
This article was originally published in the Sandler, Travis & Rosenberg Trade Report on March 13, 2019.